Volcano Corporation (NQ: VOLC)
19.33 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(VOLC) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
Related Wikinvest articles
April 18, 2014
(Stock Blog Hub, 8/8/13)
Recently, Volcano Corporation (VOLC) disclosed its plan to feature its innovative technologies, including the company’s Fractional Flow Reserve (FFR) and iFR (Instant...(read more)
(Stock Blog Hub, 5/2/13)
Recently, we have reaffirmed our Neutral recommendation on Volcano Corporation (VOLC). Although we are concerned about the company’s disappointing fourth quarter 2012 and conservative...(read more)
The market had a great day on Tuesday. Stocks closed strong, and a lot of stocks were breaking out and moving. We’ll take a look at some of the stocks that looked exceptionally good on Tuesday. Avago Technologies Limited (AVGO) has bee...
Volcano (VOLC) Company Overview

Volcano Corporation designs, develops, manufactures, and commercializes a broad suite of intravascular ultrasound, or IVUS, and functional measurement, or FM, products that it believes enhance the diagnosis and treatment of vascular and structural heart disease. The IVUS products consist of consoles, single-procedure disposable catheters, and advanced functionality options. The family of consoles includes the IVUS In-Vision Gold or IVG and the new PC-based s5, which became the primary console following its full commercial launch in mid-2006. During an IVUS procedure, an imaging catheter is placed inside an artery to produce a cross-sectional image of the size and shape of the artery's lumen and provides information concerning the composition and density of plaque or lesions and the condition of the layers of the surrounding arterial walls. As a part of the vfusion cath lab integration initiative, the company has developed customized cath lab versions of these consoles and is developing advanced functionality options. FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. These FM consoles also include a cath lab version. FM devices measure the pressure and flow characteristics of blood around plaque thereby allowing physicians to gauge the plaque s impact on blood flow and pressure. Based on product, IVUS consoles, FM consoles, disposable catheters, disposable guide wires, and other contributed 21%, 2%, 64%, 10%, and 3%, respectively, to 2006 revenue. Other revenue consist primarily of spare parts sales, service and maintenance revenues, shipping and handling revenues, and license fees. Based on geography, the U.S. and Japan contributed 50% and 29% respectively while Europe, Middle East, & Africa and rest of world contributed 17% and 4% respectively to total 2006 revenue. The company completed its initial public offering of common stock on June 15, 2006.


(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here